Biohit Oyj's Board of Directors in its meeting on June 14 elected Ph.D (Jur.), LL.M. Vesa Silaskivi as the Chairman of the Board of Directors. Silaskivi is an experienced board professional and thus a valuable contributor to the company's growth.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.02 EUR | +1.25% | -1.46% | +7.16% |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Feb. 14 | Biohit Oyj Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.16% | 32.72M | |
+7.13% | 7.91B | |
-3.15% | 4.66B | |
-9.18% | 2.84B | |
+1.11% | 2.03B | |
-26.56% | 1.12B | |
-11.09% | 816M | |
-13.49% | 755M | |
-22.71% | 759M | |
-56.85% | 682M |
- Stock Market
- Equities
- BIOBV Stock
- News Biohit Oyj
- Biohit Oyj Elects Vesa Silaskivi as Chairman of the Board of Directors